Home 2023

Colitis

StockWatch: Novo Nordisk Shares Soar as Ozempic Aces Phase III CKD Trial
Drug Discovery

StockWatch: Novo Nordisk Shares Soar as Ozempic Aces Phase III CKD Trial

Alex Philippidis -
0
Colon Cancer Accelerated by Age-Related Changes in Blood System
Cancer

Colon Cancer Accelerated by Age-Related Changes in Blood System

Christina Jackson -
0
Peptides Developed to Diagnose Common Inflammatory Diseases
News

Peptides Developed to Diagnose Common Inflammatory Diseases

Julianna LeMieux, PhD -
0
Merck to Acquire Prometheus Biosciences for $10.8B
Drug Discovery

Merck to Acquire Prometheus Biosciences for $10.8B

Alex Philippidis -
0
Pivotal Years: Abivax’s Obefazimod Faces Phase III Test
Drug Discovery

Pivotal Years: Abivax’s Obefazimod Faces Phase III Test

Alex Philippidis -
0
Metastatic Colorectal Cancers in Mice Virtually Eliminated Using Immunotherapy and Experimental Drug Combo
Cancer

Metastatic Colorectal Cancers in Mice Virtually Eliminated Using Immunotherapy and Experimental Drug Combo

Sophia Ktori -
0
StockWatch: Summit Nearly Triples on Up-to-$5B Cancer Alliance with Akeso
Cancer

StockWatch: Summit Nearly Triples on Up-to-$5B Cancer Alliance with Akeso

Alex Philippidis -
0
Inflammatory Bowel Disease Healing Hindered by Immune Cells
News

Inflammatory Bowel Disease Healing Hindered by Immune Cells

Sophia Ktori -
0
Encapsulated Probiotics Equipped with Nanoparticle Backpacks Show Promise for IBD Therapy
News

Encapsulated Probiotics Equipped with Nanoparticle Backpacks Show Promise for IBD Therapy

Sophia Ktori -
0
Amgen to Acquire ChemoCentryx for $3.7B, Bolstering Autoimmune Portfolio
Drug Discovery

Amgen to Acquire ChemoCentryx for $3.7B, Bolstering Autoimmune Portfolio

Alex Philippidis -
0
123...7Page 1 of 7
Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.